Drusolv Therapeutics
Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Drusolv Therapeutics Information
Geographic Data
Address:
City: Philadelphia
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
convertible note
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatin was developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Convertible Note | - |
Texas HALO Fund Texas HALO Fund |
5/2022 | Convertible Note | 1 | - |
Texas HALO Fund Texas HALO Fund |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
